CVS Group (LON:CVSG) Lowered to Hold Rating by Jefferies Financial Group

CVS Group (LON:CVSG) was downgraded by research analysts at Jefferies Financial Group to a “hold” rating in a research report issued on Thursday,London Stock Exchange reports. They currently have a GBX 1,350 price target on the stock, down from their prior price target of GBX 1,420. Jefferies Financial Group’s price objective suggests a potential upside of 9.67% from the company’s current price.

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, CVS Group presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,710.

CVS Group Stock Performance

Shares of LON:CVSG opened at GBX 1,231 on Thursday. The company has a market capitalization of £851.85 million, a price-to-earnings ratio of 17.87, a P/E/G ratio of 1.77 and a beta of 1.06. The firm’s 50 day simple moving average is GBX 1,195.82 and its 200 day simple moving average is GBX 1,247.82. The company has a debt-to-equity ratio of 92.34, a current ratio of 1.07 and a quick ratio of 0.90. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648.

CVS Group declared that its board has authorized a stock buyback program on Tuesday, May 26th that allows the company to buyback 0 outstanding shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Insider Transactions at CVS Group

In other CVS Group news, insider Scott Morrison purchased 987 shares of the stock in a transaction on Wednesday, May 27th. The stock was bought at an average cost of GBX 1,270 per share, for a total transaction of £12,534.90. Insiders own 1.43% of the company’s stock.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.